Left ventricular global function index assessed by cardiovascular magnetic resonance for the prediction of cardiovascular events in ST-elevation myocardial infarction
The left ventricular performance index (LVGFI) as a comprehensive marker of cardiac performance integrates LV structure with global function within one index. In a prospective cohort study of healthy individuals the LVGFI demonstrated a superior prognostic value as compared to LV ejection fraction (...
Gespeichert in:
| Veröffentlicht in: | Journal of cardiovascular magnetic resonance 2015-07, Vol.17 (1), p.62-62, Article 62 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 62 |
|---|---|
| container_issue | 1 |
| container_start_page | 62 |
| container_title | Journal of cardiovascular magnetic resonance |
| container_volume | 17 |
| creator | Eitel, Ingo Pöss, J Jobs, A Eitel, C de Waha, S Barkhausen, J Desch, S Thiele, H |
| description | The left ventricular performance index (LVGFI) as a comprehensive marker of cardiac performance integrates LV structure with global function within one index. In a prospective cohort study of healthy individuals the LVGFI demonstrated a superior prognostic value as compared to LV ejection fraction (LVEF). In patients after ST-segment elevation myocardial infarction (STEMI), however, the role of the LVGFI is unknown. Aim of this study was to investigate the relationship between the LVGFI and infarct characteristics as well as prognosis in a large multicenter STEMI population.
In total 795 STEMI patients reperfused by primary angioplasty ( |
| doi_str_mv | 10.1186/s12968-015-0161-x |
| format | Article |
| fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4502641</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A541516319</galeid><sourcerecordid>A541516319</sourcerecordid><originalsourceid>FETCH-LOGICAL-c595t-abdd1df788294f5435de406575c7113430be4abe29160c9a9faf2170723dac883</originalsourceid><addsrcrecordid>eNptkt-K1DAYxYso7rr6AN5IQFi86Zq0-dPcCMviqjDghSt4F9L0y0yWNhmTdph5IZ9z05l13VkkTVvS3zlpDqco3hJ8QUjDPyZSSd6UmLA8OSm3z4pTwuqqpJX89Ty_YylKzqk4KV6ldIsxkQKLl8VJxYmgQjanxZ8F2BFtwI_RmanXES370Ooe2cmb0QWPnO9gi3RKkK8OtTtkdOxc2Oh0EAx66WF0BkVIwWtvANkQ0bgCtI7QuYNNsE91MO-asj_6cVNCDxu9B4dd2IP5H5y3Ou7lr4sXVvcJ3tw_z4qf159vrr6Wi-9fvl1dLkrDJBtL3XYd6axomkpSy2jNOqCYM8GMIKSmNW6B6hYqSTg2UkurbUVyJlXdadM09Vnx6eC7ntoBOjPnonu1jm7QcaeCdur4i3crtQwbRRmuOCXZ4MO9QQy_J0ijGlwy0PfaQ5iSIlyKKt84zej7J-htmKLPx1NENBXmDZPiH7XUPaicSMj7mtlUXTJKGOE1kZm6-A-VRweDM8GDdXn9SHD-SLAC3Y-rFPppDjsdg-QAmhhSimAfwiBYzS1Uhxaq3EI1t1Bts-bd4xQfFH9rV98BGIbbmw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1782068597</pqid></control><display><type>article</type><title>Left ventricular global function index assessed by cardiovascular magnetic resonance for the prediction of cardiovascular events in ST-elevation myocardial infarction</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Springer Nature OA Free Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Eitel, Ingo ; Pöss, J ; Jobs, A ; Eitel, C ; de Waha, S ; Barkhausen, J ; Desch, S ; Thiele, H</creator><creatorcontrib>Eitel, Ingo ; Pöss, J ; Jobs, A ; Eitel, C ; de Waha, S ; Barkhausen, J ; Desch, S ; Thiele, H</creatorcontrib><description>The left ventricular performance index (LVGFI) as a comprehensive marker of cardiac performance integrates LV structure with global function within one index. In a prospective cohort study of healthy individuals the LVGFI demonstrated a superior prognostic value as compared to LV ejection fraction (LVEF). In patients after ST-segment elevation myocardial infarction (STEMI), however, the role of the LVGFI is unknown. Aim of this study was to investigate the relationship between the LVGFI and infarct characteristics as well as prognosis in a large multicenter STEMI population.
In total 795 STEMI patients reperfused by primary angioplasty (<12 h after symptom onset) underwent cardiovascular magnetic resonance (CMR) at 8 centers. CMR was completed within one week after infarction using a standardized protocol including LV dimensions, mass and function for calculation of the LVGFI. The primary clinical endpoint of the study was the occurrence of major adverse cardiac events (MACE).
The median LVGFI was 31.2 % (interquartile range 25.7 to 36.6). Patients with LVGFI < median had significantly larger infarcts, less myocardial salvage, a larger extent of microvascular obstruction, higher incidence of intramyocardial hemorrhage and more pronounced LV dysfunction (p < 0.001 for all). MACE and mortality rates were significantly higher in the LVGFI < median group (p < 0.001 and p = 0.003, respectively). The LVGFI had an incremental prognostic value in addition to LVEF for prediction of all-cause mortality.
The LVGFI strongly correlates with markers of severe myocardial and microvascular damage in patients with STEMI, offering prognostic information beyond traditional cardiac risk factors including the LVEF.
ClinicalTrials.gov: NCT00712101.</description><identifier>ISSN: 1097-6647</identifier><identifier>EISSN: 1532-429X</identifier><identifier>DOI: 10.1186/s12968-015-0161-x</identifier><identifier>PMID: 26174798</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Abciximab ; Aged ; Antibodies, Monoclonal - administration & dosage ; Cardiac patients ; Comparative analysis ; Diagnosis ; Female ; Germany ; Health aspects ; Heart attack ; Humans ; Immunoglobulin Fab Fragments - administration & dosage ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Mortality ; Myocardial Contraction ; Myocardial Infarction - diagnosis ; Myocardial Infarction - mortality ; Myocardial Infarction - physiopathology ; Myocardial Infarction - therapy ; Percutaneous Coronary Intervention ; Platelet Aggregation Inhibitors - administration & dosage ; Predictive Value of Tests ; Prospective Studies ; Risk Factors ; Stroke Volume ; Time Factors ; Treatment Outcome ; Ventricular Dysfunction, Left - diagnosis ; Ventricular Dysfunction, Left - mortality ; Ventricular Dysfunction, Left - physiopathology ; Ventricular Dysfunction, Left - therapy ; Ventricular Function, Left</subject><ispartof>Journal of cardiovascular magnetic resonance, 2015-07, Vol.17 (1), p.62-62, Article 62</ispartof><rights>COPYRIGHT 2015 BioMed Central Ltd.</rights><rights>Copyright BioMed Central 2015</rights><rights>Eitel et al. 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c595t-abdd1df788294f5435de406575c7113430be4abe29160c9a9faf2170723dac883</citedby><cites>FETCH-LOGICAL-c595t-abdd1df788294f5435de406575c7113430be4abe29160c9a9faf2170723dac883</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4502641/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4502641/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26174798$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Eitel, Ingo</creatorcontrib><creatorcontrib>Pöss, J</creatorcontrib><creatorcontrib>Jobs, A</creatorcontrib><creatorcontrib>Eitel, C</creatorcontrib><creatorcontrib>de Waha, S</creatorcontrib><creatorcontrib>Barkhausen, J</creatorcontrib><creatorcontrib>Desch, S</creatorcontrib><creatorcontrib>Thiele, H</creatorcontrib><title>Left ventricular global function index assessed by cardiovascular magnetic resonance for the prediction of cardiovascular events in ST-elevation myocardial infarction</title><title>Journal of cardiovascular magnetic resonance</title><addtitle>J Cardiovasc Magn Reson</addtitle><description>The left ventricular performance index (LVGFI) as a comprehensive marker of cardiac performance integrates LV structure with global function within one index. In a prospective cohort study of healthy individuals the LVGFI demonstrated a superior prognostic value as compared to LV ejection fraction (LVEF). In patients after ST-segment elevation myocardial infarction (STEMI), however, the role of the LVGFI is unknown. Aim of this study was to investigate the relationship between the LVGFI and infarct characteristics as well as prognosis in a large multicenter STEMI population.
In total 795 STEMI patients reperfused by primary angioplasty (<12 h after symptom onset) underwent cardiovascular magnetic resonance (CMR) at 8 centers. CMR was completed within one week after infarction using a standardized protocol including LV dimensions, mass and function for calculation of the LVGFI. The primary clinical endpoint of the study was the occurrence of major adverse cardiac events (MACE).
The median LVGFI was 31.2 % (interquartile range 25.7 to 36.6). Patients with LVGFI < median had significantly larger infarcts, less myocardial salvage, a larger extent of microvascular obstruction, higher incidence of intramyocardial hemorrhage and more pronounced LV dysfunction (p < 0.001 for all). MACE and mortality rates were significantly higher in the LVGFI < median group (p < 0.001 and p = 0.003, respectively). The LVGFI had an incremental prognostic value in addition to LVEF for prediction of all-cause mortality.
The LVGFI strongly correlates with markers of severe myocardial and microvascular damage in patients with STEMI, offering prognostic information beyond traditional cardiac risk factors including the LVEF.
ClinicalTrials.gov: NCT00712101.</description><subject>Abciximab</subject><subject>Aged</subject><subject>Antibodies, Monoclonal - administration & dosage</subject><subject>Cardiac patients</subject><subject>Comparative analysis</subject><subject>Diagnosis</subject><subject>Female</subject><subject>Germany</subject><subject>Health aspects</subject><subject>Heart attack</subject><subject>Humans</subject><subject>Immunoglobulin Fab Fragments - administration & dosage</subject><subject>Magnetic Resonance Imaging</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Myocardial Contraction</subject><subject>Myocardial Infarction - diagnosis</subject><subject>Myocardial Infarction - mortality</subject><subject>Myocardial Infarction - physiopathology</subject><subject>Myocardial Infarction - therapy</subject><subject>Percutaneous Coronary Intervention</subject><subject>Platelet Aggregation Inhibitors - administration & dosage</subject><subject>Predictive Value of Tests</subject><subject>Prospective Studies</subject><subject>Risk Factors</subject><subject>Stroke Volume</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><subject>Ventricular Dysfunction, Left - diagnosis</subject><subject>Ventricular Dysfunction, Left - mortality</subject><subject>Ventricular Dysfunction, Left - physiopathology</subject><subject>Ventricular Dysfunction, Left - therapy</subject><subject>Ventricular Function, Left</subject><issn>1097-6647</issn><issn>1532-429X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNptkt-K1DAYxYso7rr6AN5IQFi86Zq0-dPcCMviqjDghSt4F9L0y0yWNhmTdph5IZ9z05l13VkkTVvS3zlpDqco3hJ8QUjDPyZSSd6UmLA8OSm3z4pTwuqqpJX89Ty_YylKzqk4KV6ldIsxkQKLl8VJxYmgQjanxZ8F2BFtwI_RmanXES370Ooe2cmb0QWPnO9gi3RKkK8OtTtkdOxc2Oh0EAx66WF0BkVIwWtvANkQ0bgCtI7QuYNNsE91MO-asj_6cVNCDxu9B4dd2IP5H5y3Ou7lr4sXVvcJ3tw_z4qf159vrr6Wi-9fvl1dLkrDJBtL3XYd6axomkpSy2jNOqCYM8GMIKSmNW6B6hYqSTg2UkurbUVyJlXdadM09Vnx6eC7ntoBOjPnonu1jm7QcaeCdur4i3crtQwbRRmuOCXZ4MO9QQy_J0ijGlwy0PfaQ5iSIlyKKt84zej7J-htmKLPx1NENBXmDZPiH7XUPaicSMj7mtlUXTJKGOE1kZm6-A-VRweDM8GDdXn9SHD-SLAC3Y-rFPppDjsdg-QAmhhSimAfwiBYzS1Uhxaq3EI1t1Bts-bd4xQfFH9rV98BGIbbmw</recordid><startdate>20150716</startdate><enddate>20150716</enddate><creator>Eitel, Ingo</creator><creator>Pöss, J</creator><creator>Jobs, A</creator><creator>Eitel, C</creator><creator>de Waha, S</creator><creator>Barkhausen, J</creator><creator>Desch, S</creator><creator>Thiele, H</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7SC</scope><scope>7SP</scope><scope>7U5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>JQ2</scope><scope>K9.</scope><scope>L7M</scope><scope>LK8</scope><scope>L~C</scope><scope>L~D</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>M7Z</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20150716</creationdate><title>Left ventricular global function index assessed by cardiovascular magnetic resonance for the prediction of cardiovascular events in ST-elevation myocardial infarction</title><author>Eitel, Ingo ; Pöss, J ; Jobs, A ; Eitel, C ; de Waha, S ; Barkhausen, J ; Desch, S ; Thiele, H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c595t-abdd1df788294f5435de406575c7113430be4abe29160c9a9faf2170723dac883</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Abciximab</topic><topic>Aged</topic><topic>Antibodies, Monoclonal - administration & dosage</topic><topic>Cardiac patients</topic><topic>Comparative analysis</topic><topic>Diagnosis</topic><topic>Female</topic><topic>Germany</topic><topic>Health aspects</topic><topic>Heart attack</topic><topic>Humans</topic><topic>Immunoglobulin Fab Fragments - administration & dosage</topic><topic>Magnetic Resonance Imaging</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Myocardial Contraction</topic><topic>Myocardial Infarction - diagnosis</topic><topic>Myocardial Infarction - mortality</topic><topic>Myocardial Infarction - physiopathology</topic><topic>Myocardial Infarction - therapy</topic><topic>Percutaneous Coronary Intervention</topic><topic>Platelet Aggregation Inhibitors - administration & dosage</topic><topic>Predictive Value of Tests</topic><topic>Prospective Studies</topic><topic>Risk Factors</topic><topic>Stroke Volume</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><topic>Ventricular Dysfunction, Left - diagnosis</topic><topic>Ventricular Dysfunction, Left - mortality</topic><topic>Ventricular Dysfunction, Left - physiopathology</topic><topic>Ventricular Dysfunction, Left - therapy</topic><topic>Ventricular Function, Left</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Eitel, Ingo</creatorcontrib><creatorcontrib>Pöss, J</creatorcontrib><creatorcontrib>Jobs, A</creatorcontrib><creatorcontrib>Eitel, C</creatorcontrib><creatorcontrib>de Waha, S</creatorcontrib><creatorcontrib>Barkhausen, J</creatorcontrib><creatorcontrib>Desch, S</creatorcontrib><creatorcontrib>Thiele, H</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Computer and Information Systems Abstracts</collection><collection>Electronics & Communications Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Computer Science Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>ProQuest Biological Science Collection</collection><collection>Computer and Information Systems Abstracts Academic</collection><collection>Computer and Information Systems Abstracts Professional</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Biochemistry Abstracts 1</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of cardiovascular magnetic resonance</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Eitel, Ingo</au><au>Pöss, J</au><au>Jobs, A</au><au>Eitel, C</au><au>de Waha, S</au><au>Barkhausen, J</au><au>Desch, S</au><au>Thiele, H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Left ventricular global function index assessed by cardiovascular magnetic resonance for the prediction of cardiovascular events in ST-elevation myocardial infarction</atitle><jtitle>Journal of cardiovascular magnetic resonance</jtitle><addtitle>J Cardiovasc Magn Reson</addtitle><date>2015-07-16</date><risdate>2015</risdate><volume>17</volume><issue>1</issue><spage>62</spage><epage>62</epage><pages>62-62</pages><artnum>62</artnum><issn>1097-6647</issn><eissn>1532-429X</eissn><abstract>The left ventricular performance index (LVGFI) as a comprehensive marker of cardiac performance integrates LV structure with global function within one index. In a prospective cohort study of healthy individuals the LVGFI demonstrated a superior prognostic value as compared to LV ejection fraction (LVEF). In patients after ST-segment elevation myocardial infarction (STEMI), however, the role of the LVGFI is unknown. Aim of this study was to investigate the relationship between the LVGFI and infarct characteristics as well as prognosis in a large multicenter STEMI population.
In total 795 STEMI patients reperfused by primary angioplasty (<12 h after symptom onset) underwent cardiovascular magnetic resonance (CMR) at 8 centers. CMR was completed within one week after infarction using a standardized protocol including LV dimensions, mass and function for calculation of the LVGFI. The primary clinical endpoint of the study was the occurrence of major adverse cardiac events (MACE).
The median LVGFI was 31.2 % (interquartile range 25.7 to 36.6). Patients with LVGFI < median had significantly larger infarcts, less myocardial salvage, a larger extent of microvascular obstruction, higher incidence of intramyocardial hemorrhage and more pronounced LV dysfunction (p < 0.001 for all). MACE and mortality rates were significantly higher in the LVGFI < median group (p < 0.001 and p = 0.003, respectively). The LVGFI had an incremental prognostic value in addition to LVEF for prediction of all-cause mortality.
The LVGFI strongly correlates with markers of severe myocardial and microvascular damage in patients with STEMI, offering prognostic information beyond traditional cardiac risk factors including the LVEF.
ClinicalTrials.gov: NCT00712101.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>26174798</pmid><doi>10.1186/s12968-015-0161-x</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1097-6647 |
| ispartof | Journal of cardiovascular magnetic resonance, 2015-07, Vol.17 (1), p.62-62, Article 62 |
| issn | 1097-6647 1532-429X |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4502641 |
| source | MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Springer Nature OA Free Journals; PubMed Central; Alma/SFX Local Collection |
| subjects | Abciximab Aged Antibodies, Monoclonal - administration & dosage Cardiac patients Comparative analysis Diagnosis Female Germany Health aspects Heart attack Humans Immunoglobulin Fab Fragments - administration & dosage Magnetic Resonance Imaging Male Middle Aged Mortality Myocardial Contraction Myocardial Infarction - diagnosis Myocardial Infarction - mortality Myocardial Infarction - physiopathology Myocardial Infarction - therapy Percutaneous Coronary Intervention Platelet Aggregation Inhibitors - administration & dosage Predictive Value of Tests Prospective Studies Risk Factors Stroke Volume Time Factors Treatment Outcome Ventricular Dysfunction, Left - diagnosis Ventricular Dysfunction, Left - mortality Ventricular Dysfunction, Left - physiopathology Ventricular Dysfunction, Left - therapy Ventricular Function, Left |
| title | Left ventricular global function index assessed by cardiovascular magnetic resonance for the prediction of cardiovascular events in ST-elevation myocardial infarction |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T18%3A00%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Left%20ventricular%20global%20function%20index%20assessed%20by%20cardiovascular%20magnetic%20resonance%20for%20the%20prediction%20of%20cardiovascular%20events%20in%20ST-elevation%20myocardial%20infarction&rft.jtitle=Journal%20of%20cardiovascular%20magnetic%20resonance&rft.au=Eitel,%20Ingo&rft.date=2015-07-16&rft.volume=17&rft.issue=1&rft.spage=62&rft.epage=62&rft.pages=62-62&rft.artnum=62&rft.issn=1097-6647&rft.eissn=1532-429X&rft_id=info:doi/10.1186/s12968-015-0161-x&rft_dat=%3Cgale_pubme%3EA541516319%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1782068597&rft_id=info:pmid/26174798&rft_galeid=A541516319&rfr_iscdi=true |